Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Polypharmacotherapy and cumulative anticholinergic burden in older adults hospitalised with fall
  • +6
  • Ho Lun Wong,
  • Claire Weaver,
  • Lauren Marsh,
  • Khine Mon,
  • John Dapito,
  • Rahul Chauhan,
  • Amit Mandal,
  • Constantinos Missouris,
  • Fouad Amin
Ho Lun Wong
Wexham Park Hospital

Corresponding Author:[email protected]

Author Profile
Claire Weaver
Wexham Park Hospital
Author Profile
Lauren Marsh
Wexham Park Hospital
Author Profile
Khine Mon
Wexham Park Hospital
Author Profile
John Dapito
Wexham Park Hospital
Author Profile
Rahul Chauhan
Wexham Park Hospital
Author Profile
Amit Mandal
Wexham Park Hospital
Author Profile
Constantinos Missouris
Wexham Park Hospital
Author Profile
Fouad Amin
Wexham Park Hospital
Author Profile

Abstract

Background and Purpose Polypharmacotherapy is a growing phenomenon associated with adverse effects in older adults. We assessed the potential confounding effects of cumulative anticholinergic burden (ACB) in patients who were hospitalised with falls. Methods A non-interventional, prospective cohort study of unselected, acute admissions aged ≥65 years. Data were derived from electronic patient health records. Results were analysed to determine the frequency of polypharmacotherapy and degree of ACB and their relationship to falls risk. Primary outcomes were polypharmacotherapy, defined by ≥5 medications, and ACB score. Key Results 411 consecutive subjects were included, mean age 83·8 ± 8·0 years: 40·6% male. 38·4% were admitted with fall. Incidence of polypharmacotherapy was 80·8%, (88·0% and 76·3% among those admitted with and without fall respectively). Incidence of ACB score of 0, 1, 2, ≥3 was 38·7%, 20·9%, 14·6% and 25·8% respectively. On multivariate analysis, age (OR=1·03, [1·0 ; 1·05], p= 0·0494), ACB score (OR=1.15, [1.02 ; 1.29], p= 0.0245), polypharmacotherapy (OR=2·14, [1·19 ; 3·87], p= 0·0115) but not Charlson Comorbidity Index (OR=0·92, [0·81 ; 1·04], p= 0·1723) were significantly associated with higher falls rate. Of patients admitted with fall, 29·8% had drug-related orthostatic hypotension, 24·7% had drug-related bradycardia, 37·3% were prescribed centrally acting drugs and 12·0% were taking inappropriate hypoglycaemic agents. Interpretation Polypharmacotherapy results in cumulative ACB and both are significantly associated with falls risk in older adults. The presence of polypharmacotherapy and each unit rise in ACB score have a stronger effect of increasing falls risk compared to age and comorbidities.